Agios amends severance plan; expands C-Level definition, alters equity vesting rules

AGIOS PHARMACEUTICALS, INC.

C-Level Employee definition expanded to include any job title above Senior Vice President.
New-Hire Equity Awards granted after October 6, 2022 will have accelerated vesting on non-Change-of-Control termination or death/disability.
Change-of-Control Termination now triggers full vesting of service-based equity awards; performance awards per original plan terms.
Post-Change-of-Control amendment/termination restriction period increased from 12 to 18 months.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.